Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ffbe71cb54b92414ad178bb647126c1d |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 |
filingDate |
2017-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c42e3780ef7ea3241e8a3d8eabd2e4ac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b916b7b625bea15e747b6227c244a68d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6637b24d9c78168dc31848682211b7db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c46442fbb184b4b12ee26b36d6b9e43e |
publicationDate |
2019-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
TR-201722630-A2 |
titleOfInvention |
PHARMACEUTICAL TABLET COMPOSITIONS OF DABIGATRAN |
abstract |
The present invention relates to pharmaceutical tablet compositions for oral administration containing dabigatran etexilate free base or pharmaceutically acceptable salts of dabigatran etexilate and at least one pharmaceutically acceptable excipient. |
priorityDate |
2017-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |